Induction Chemotherapy
Induction Chemotherapy is a pharmaceutical drug with 24 clinical trials. Currently 7 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
17
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
45.5%
5 of 11 finished
54.5%
6 ended early
7
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Clinical Trials (24)
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer
Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma
Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer
Post Transplant Donor Lymphocyte Infusion
Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors
A Study of Tongue Conservation Surgery for Oral Tongue Cancer
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24